Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Prolonged exposure therapy is more effective in treating veterans with PTSD, alcohol use disorder

Prolonged exposure therapy is more effective in treating veterans with PTSD, alcohol use disorder

Prolonged exposure therapy is more effective at treating PTSD than Seeking Safety, a coping skills therapy, for patients who also have alcohol use disorder, found a VA San Diego Healthcare System study. The findings offer important guidance for clinicians in the VA health care system, which cares for many veterans coping with both PTSD and problem drinking.

The researchers compared patients who were given integrated alcohol and prolonged exposure treatment with those given integrated alcohol and coping skills treatment. Both treatments reduced PTSD symptoms and heavy drinking. But patients receiving prolonged exposure therapy had significantly lower scores on a measure of PTSD symptoms. The researchers concluded that prolonged exposure therapy should be offered to patients with PTSD whenever possible, including to patients with alcohol use disorder.

The results will appear in the April 24, 2019, issue of JAMA Psychiatry.

The study was led by Dr. Sonya Norman, a researcher at the San Diego VA, director of the PTSD Consultation Program for the National Center for PTSD, and a professor of psychiatry at the University of California San Diego. Norman explained that the results could lead to better treatment for PTSD. “The research is not showing concerns that PTSD patients with alcohol use disorder can’t handle exposure to be true,” she said. “The main takeaway of the study for me is that we may be doing a disservice to veterans if we don’t offer them the best treatments we have available for PTSD, such as prolonged exposure.”

PTSD and alcohol use disorder commonly occur together. A 2011 study by San Francisco VA Medical Center researchers found that 55% to 75% of Iraq and Afghanistan veterans receiving care through VA who had an alcohol or substance use disorder also had a PTSD or depression diagnosis. They are both linked to psychiatric and personal problems. People with both PTSD and alcohol use disorder tend to have shorter periods of abstinence from drinking. They also have a greater risk of suicide and homelessness, as well as more legal and psychological problems, than people with only one of the conditions.

Prolonged exposure therapy is considered a gold standard for PTSD treatment. In this psychotherapy, patients gradually approach memories, feelings, and situations related to their trauma. The goal is for them to be able to face memories and thoughts related to trauma without triggering anxiety and stress.

Much research has shown prolonged exposure therapy to be the most effective treatment for PTSD. However, many patients with both PTSD and alcohol use disorder are not offered the treatment, according to the researchers. Therapists are often concerned that exposure to traumatic memories may lead to increased drinking.

Seeking Safety, a widely accepted psychotherapy for co-occurring PTSD and alcohol use disorder, focuses on coping skills rather than exposure. The thought is that establishing safety through better coping skills is the first priority, and that eliciting traumatic memories too early may be harmful–and may trigger drinking.

To compare the two approaches, researchers recruited 119 patients with both PTSD and alcohol use disorder. One group was given integrated prolonged exposure therapy, and a second group was given Seeking Safety. Both types of treatment incorporated cognitive behavioral intervention for alcohol use disorder alongside the PTSD psychotherapy.

Both interventions led to fewer days of heavy drinking and a decrease in PTSD symptoms, as measured by the Clinician Administered PTSD Scale-5. While both treatments lowered PTSD symptoms, patients who received prolonged exposure had significantly lower PTSD symptom scores, as well as higher rates of PTSD remission.

Immediately after treatment, 22% of prolonged exposure patients had achieved PTSD remission, compared with 7% in the coping skills group. Three months after treatment, those numbers were 25% versus 6%. After six months, 33% of prolonged exposure patients were in remission, while only 15% of coping skills patients were.

Patients in both groups reported high levels of satisfaction with their treatment. Patients in both groups also had fewer heavy drinking days after treatment. This reduction in drinking was not significantly different between groups, contrary to the researchers’ expectations. They speculate that this result could be due to the similarity between the cognitive behavioral interventions used for each group. Although the prolonged exposure group did not have less heavy drinking than the coping skills group as the researchers expected, exposure therapy did not lead to increased drinking, as many experts in the field might think it would.

The results show that prolonged exposure therapy is more effective at treating PTSD than treatment without exposure regardless of whether patients also have alcohol use disorder, say the researchers. They conclude that many patients may not be getting the most effective treatment because of their alcohol use disorder.

Coping skills therapy still has its uses, according to the researchers. Coping skills therapy may be useful when patients refuse prolonged exposure or when prolonged exposure is not available, but the researchers say their results suggest that prolonged exposure should be the first line of treatment for patients with PTSD and alcohol use disorder.

Research into prolonged exposure therapy continues. “The next stage of this research,” explained Norman, “is to learn how to make prolonged exposure even more effective for patients with PTSD and alcohol use disorder. We are now conducting a study where we are combining medication to help reduce drinking with prolonged exposure to see if the combination helps patients complete prolonged exposure and benefit even more from the treatment.”


Tagged with:

About author

Related Articles